Toxic liver disease with hepatic necrosis
ICD-10 K71.1 is a used to indicate a diagnosis of toxic liver disease with hepatic necrosis.
Toxic liver disease with hepatic necrosis, classified under ICD-10 code K71.1, is characterized by liver damage resulting from exposure to toxic substances, including drugs, alcohol, and environmental toxins. Clinically, patients may present with symptoms such as jaundice, abdominal pain, nausea, vomiting, and altered mental status, indicating severe liver dysfunction. The liver, a vital organ in the digestive system, plays a crucial role in metabolizing substances and detoxifying harmful compounds. In cases of hepatic necrosis, the liver cells undergo cell death, leading to impaired liver function and potential complications such as liver failure. Disease progression can vary based on the toxin involved, duration of exposure, and individual patient factors. Diagnostic considerations include liver function tests, imaging studies, and possibly liver biopsy to assess the extent of necrosis. Early identification and management are essential to prevent irreversible liver damage and improve patient outcomes.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
K71.1 covers liver damage specifically due to toxic agents leading to hepatic necrosis. This includes drug-induced liver injury, acute liver failure from acetaminophen overdose, and other chemical exposures that result in significant liver cell death.
K71.1 should be used when there is clear evidence of hepatic necrosis due to toxic exposure. If liver damage is present without necrosis, K71.0 should be used instead. Accurate clinical assessment and documentation are crucial for appropriate code selection.
Documentation should include a detailed patient history of toxin exposure, clinical symptoms, laboratory results indicating liver function impairment, and imaging studies if performed. A clear treatment plan and follow-up assessments are also essential.
